Global access disparity: difference between revisions
Diff·revision 9 → 10·21:19, 21 Apr 2025
Difference between revision 9 and revision 10 of Global access disparity. 6 lines changed; the page grew by 581 bytes.
| Revision 9 — 05:38, 2 Apr 2025 Chromatokid (talk) attribute the survey figure to the survey and give its sample size 2,619 bytes ±0 | Revision 10 — 21:19, 21 Apr 2025 AppealsArno (talk) fix the anchor on an internal link 3,200 bytes +581 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Global access disparity | 2 | | name = Global access disparity |
| + | 3 | | subtitle = Health equity | |
| 3 | | Drivers = Price, manufacturing capacity, regulatory approval, coverage | 4 | | Drivers = Price, manufacturing capacity, regulatory approval, coverage |
| 4 | | Consequence = Availability tracks income between and within countries | 5 | | Consequence = Availability tracks income between and within countries |
| ⋮ | ⋮ | ||
| 17 | 18 | ||
| 18 | Capacity expansion has been substantial since, and the constraint has eased in some markets. Whether that translates into broader availability depends on price and approval rather than on capacity alone.{{r|ada2024}} | 19 | Capacity expansion has been substantial since, and the constraint has eased in some markets. Whether that translates into broader availability depends on price and approval rather than on capacity alone.{{r|ada2024}} |
| + | 20 | ||
| + | 21 | == Approval and coverage == | |
| + | 22 | A product cannot be sold where it is not approved, and applications are filed where a market is expected. Approval therefore follows commercial assessment as much as need. See [[Regulatory status by jurisdiction]].{{r|ada2024}} | |
| + | 23 | ||
| + | 24 | Where approved, coverage decisions determine affordability. Weight-management indications are covered less often than glycaemic ones in many systems, and out-of-pocket cost at list price exceeds what most households can sustain for a chronic therapy. See [[Cost per milligram]].{{r|kyle2021}} | |
| 19 | 25 | ||
| 20 | == References == | 26 | == References == |